Editorial

By Karen Roman Prolium Bioscience, Inc. said it dosed its first patient in Phase 1/2...

By Karen Roman Veraxa Biotech AG (Nasdaq: VRXA) reported in vitro proof-of-concept data validating its...

By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS) said it nominated ACU301 and ACU401, two...

Download the Complete Report Here Aurora Cannabis Inc. (ACB) Y26 Beat Underscores Medical Cannabis Momentum;...

By Karen Roman Enhanced Group Inc. (NYSE: ENHA) said it closed a $50 million private...

Suja Life, Inc. (Nasdaq: SUJA) debuted last month, offering investors exposure to the leading platform...

By Karen Roman Imviva Biotech said it is presenting two findings associated with relapsed or...

By Karen Roman Suja Life, Inc. (Nasdaq: SUJA) said first quarter net sales grew 22.5%...

By Karen Roman Imviva Biotech said the FDA cleared its Investigational New Drug application for...

Watch Video Highlights Below, or Click HERE:  Tech Edge hosted firesides live from Pax8 Beyond 2026...